You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Small cell lung cancer (SCLC)

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Relapsed Small Cell Lung Cancer Trial in Beijing (Irinotecan HCl liposome Injection, Topotecan)

Not yet recruiting
  • Relapsed Small Cell Lung Cancer
  • Irinotecan hydrochloride liposome Injection
  • Topotecan
  • Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences
Nov 7, 2023

EGFR-Mutated Non-Small-Cell Lung Carcinoma, Small Cell/Neuroendocrine Trial run by the National Cancer Institute (NCI)

Recruiting
  • EGFR-Mutated Non-Small-Cell Lung Carcinoma
  • Small Cell/Neuroendocrine
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 20, 2023

Small-cell Lung Cancer, Relapsed Small Cell Lung Cancer, Recurrent Small Cell Lung Cancer Trial in Kissimmee, Tampa (Nivolumab,

Recruiting
  • Small-cell Lung Cancer
  • +2 more
  • Kissimmee, Florida
  • +1 more
Nov 2, 2022

Small Cell Lung Cancer Trial in Saint Louis (AL8326 low dose group, AL8326 middle dose group, AL8326 high dose group)

Recruiting
  • Small Cell Lung Cancer
  • AL8326 low dose group
  • +2 more
  • Saint Louis, Missouri
    Siteman cancer center, Washington University
Nov 1, 2022

Small Cell Lung Cancer (SCLC) Trial (Tarlatamab, Lurbinectedin, Topotecan)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • (no location specified)
Feb 21, 2023

Small-cell Lung Cancer, Brain Metastases Trial in United States (Carboplatin, Etoposide, Atezolizumab)

Active, not recruiting
  • Small-cell Lung Cancer
  • Brain Metastases
  • Duarte, California
  • +5 more
Oct 10, 2022

SCLC Trial in Changchun (PM8002, Paclitaxel)

Recruiting
  • SCLC
  • Changchun, China
    Jilin Provincial Tumor Hospital
May 25, 2023

Small Cell Lung Cancer (SCLC) Trial in Guangzhou (Anlotinib Tislelizumab Irinotecan)

Recruiting
  • Small Cell Lung Cancer (SCLC)
  • Anlotinib Tislelizumab Irinotecan
  • Guangzhou, Guangdong, China
    Guangdong Provincial Hospital of Traditional Chinese Medicine
Jun 30, 2022

Treatment Patterns in Advanced Small Cell Lung Cancer (SCLC)

Completed
  • Lung Cancer
    • Barcelona, Spain
    • +1 more
    Jan 11, 2022

    Safety and Efficacy of Zepzelca™ Injection

    Recruiting
    • SCLC
      • Seoul, Korea, Republic of
        Seoul National University Boramae Medical Center
      Aug 28, 2023

      Reveal Patterns of Presentation, Management and Outcome of SCLC

      Recruiting
      • Lung Cancer
        • Dammam, Saudi Arabia
        • +2 more
        Jul 25, 2022

        Molecular Analysis and Treatment Options of SCLC

        Recruiting
        • Small-cell Lung Cancer
        • +4 more
        • Shanghai, China
          Shanghai Chest Hospital
        Jul 6, 2023

        Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

        Not yet recruiting
        • Small Cell Lung Cancer (SCLC)
        • +3 more
        • (no location specified)
        Dec 7, 2022

        Small Cell Lung Cancer Extensive Stage Trial in France, Luxembourg (Carboplatin + Paclitaxel + Durvalumab)

        Not yet recruiting
        • Small Cell Lung Cancer Extensive Stage
        • Carboplatin + Paclitaxel + Durvalumab
        • Abbeville, France
        • +27 more
        May 4, 2023

        Small Cell Lung Cancer (SCLC) Trial in New York (biological, drug, radiation)

        Terminated
        Has Results
        • Small Cell Lung Cancer (SCLC)
        • Pembrolizumab
        • +4 more
        • New York, New York
          Laura and Isaac Perlmutter Cancer Center at NYU Langone
        Oct 18, 2021

        Extensive Stage Small Cell Lung Carcinoma Trial in United States (Pembrolizumab, Laboratory Biomarker Analysis)

        Active, not recruiting
        Has Results
        • Extensive Stage Small Cell Lung Carcinoma
        • Pembrolizumab
        • Laboratory Biomarker Analysis
        • Chicago, Illinois
        • +4 more
        Jun 28, 2022

        Extensive Stage Small Cell Lung Cancer (ES-SCLC) Trial (HS-20093)

        Not yet recruiting
        • Extensive Stage Small Cell Lung Cancer (ES-SCLC)
        • (no location specified)
        Sep 19, 2023

        Extensive-stage Small Cell Lung Cancer Trial in Changsha (Radiation Therapy)

        Completed
        • Extensive-stage Small Cell Lung Cancer
        • Radiation Therapy
        • Changsha, Hunan, China
        • +1 more
        Jun 10, 2022

        Limited-stage Small Cell Lung Cancer (LS-SCLC) Trial in Jinan (Tifcemalimab injection, toripalimab injection, Placebo for

        Not yet recruiting
        • Limited-stage Small Cell Lung Cancer (LS-SCLC)
        • Tifcemalimab injection
        • +3 more
        • Jinan, Shandong, China
          Shandong Cancer Hospital & Institute
        Oct 18, 2023

        Small Cell Lung Cancer (SCLC) Trial in Beijing (JK-1201I)

        Recruiting
        • Small Cell Lung Cancer (SCLC)
        • Beijing, Beijing, China
          Beijing Cancer Hospital
        Dec 14, 2021

        Molecular Subtyping of Extensive Stage Small Cell Lung Cancer

        Recruiting
        • SCLC,Extensive Stage
        • PD-(L)1 antibody immunotherapy
        • Beijing, Beijing, China
          Peking University Cancer Hospital & Institute
        Jul 3, 2023

        Lung Cancer, Lung Cancer Metastatic, Brain Metastases Trial in United States (Stereotactic Radiosurgery, Cerebrospinal fluid

        Recruiting
        • Lung Cancer
        • +5 more
        • Stereotactic Radiosurgery
        • Cerebrospinal fluid collection
        • Basking Ridge, New Jersey
        • +6 more
        Nov 11, 2022

        Extensive-stage Small-cell Lung Cancer Trial (Trilaciclib, Placebo, Topotecan)

        Not yet recruiting
        • Extensive-stage Small-cell Lung Cancer
        • (no location specified)
        May 22, 2023

        Small Cell Lung Cancer Extensive Stage Trial (quaratusugene ozeplasmid, atezolizumab)

        Not yet recruiting
        • Small Cell Lung Cancer Extensive Stage
        • quaratusugene ozeplasmid
        • atezolizumab
        • (no location specified)
        Jan 19, 2023

        Small Cell Lung Cancer Trial in New Haven (Combination immunotherapy with Ipilimumab and Nivolumab)

        Active, not recruiting
        • Small Cell Lung Cancer
        • Combination immunotherapy with Ipilimumab and Nivolumab
        • New Haven, Connecticut
          Yale University, Yale Cancer Center
        Apr 21, 2022